BlankNovel Treatments for Chronic Lymphocytic Leukemia Susan R. Peck, PhD Published Online: Friday, April 20th, 2012 At the 16th Annual International Congress...
Greetings, PAL is a participating member of the Lymphoma Coalition, which designed a survey to gather information so we can understand your journey and support...
T-Lymphocytes in Treating Patients With Active or Relapsed Hodgkin Lymphoma or Non-Hodgkin Lymphoma http://1.usa.gov/H21C18 "antigens" are unique proteins that...
Re: Need to treat vs. Need to treat anticipated soon. Would you agree ... ... that the latter seems the more appropriate clinical circumstance to consider...
hLL1-dox (IMMU-110) is a drug immunoconjugate composed of dox (doxorubicin) conjugated to hLL1 (an anti-cd74 antibody) ... "Due to its rapid internalization...
on the day we cure cancer ... KevinMD: On the day we cure cancer http://bit.ly/J1DUUh All the best, ~ Karl Patients Against Lymphoma Patients Helping Patients ...
Medscape: First Formal Guidelines for Cancer Survivorship "Maintaining a healthy weight, getting adequate physical activity, and eating a healthy diet can...
Well, no, but interesting nevertheless From Margaret's Corner blog: http://margaret.healthblogs.org LIVING WITH SMOLDERING MYELOMA Cancer-killing dandelion tea...
Greetings, I think there can also be overlapping features between CLL and MCL ... on dim recall ... which supports the notion that a second evaluation of your ...
Greetings, I'm not sure that you will have access to the full text of this perspective, so have copied some of the points that resonated with me. == ...
Greetings, Graft versus host disease(GvHD) is a complication of allogeneic stem cell rescue (or SCT) - where the engrafted immune cells attacks normal tissue. ...
Greetings, It's too early to say that adding ABT-199 to BR will be safe and also improve efficacy, but the concept is compelling - the notion of building on ...
BlankInverse association between soy intake and non-Hodgkin lymphoma risk among women: a case–control study in Japan Correspondence to: Dr Keitaro Matsuo,...
BlankDesign of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia. C Billard Leukemia, March 28, 2012; . Centre de Recherche des Cordeliers,...
Featuring this month: Expert panel (Cheson and others) on Longer-term Safety Data for Bendamustine-Rituxan PAL http://bit.ly/KfEDRQ All the best, ~ Karl ...
Weill Cornell; John Leonard discusses Antibody therapy http://bit.ly/J2yB5p All the best, ~ Karl Patients Against Lymphoma Patients Helping Patients Non-profit...
Greetings, This was a pre-planned subgroup analysis for subtypes of NHL that are under-studied because they are relatively uncommon types of indolent lymphoma....
BlankChronic Lymphocytic Leukemia Drug Treatment Shows Promise An experimental drug, called ibrutinib, shows promise treating elderly patients with chronic...
BlankChronic Lymphocytic Leukemia Therapy: Beyond Chemoimmunotherapy? E Montserrat, J Delgado, T Baumann, and G Ghita Curr Pharm Des, May 10, 2012; Institute...
BlankMicroenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy. MD Bo, R...
BlankTherapy of elderly/comorbid patients with chronic lymphocytic leukemia. L Smolej Curr Pharm Des, May 10, 2012; . 2nd Department of Medicine Department of...
BlankZGDHu-1 promotes apoptosis of chronic lymphocytic leukemia cells. LN Qiu, YL Zhou, ZN Wang, Q Huang, and WX Hu Int J Oncol, May 8, 2012; . Centre of...
Hi Everyone The Patient Experience is looking for people who wish to write blogs on medical subjects Please click below if you would like to find out more ...
ASCO Post: Progress in Treating Chronic Lymphocytic Leukemia Has Led to Across-the-board Improvements in Survival A Conversation with Kanti R. Rai, MD ...
BlankPsychiatric Drug May Kill Cancer Stem Cells A well-known drug for treating schizophrenia may be a cancer killer, too. In lab studies, the drug wiped out a...
Greetings, While conversing with a friend and fellow anti-fracturing advocate in my home region of PA ... the conversation turned to cancer and my work - and ...
ASCO groups CLL abstracts in the leukemia section, ASH combines CLL with lymphoma. I think ASH has it right ... but why quibble? ASCO CLL abstracts can be...
Combination of the Bruton's tyrosine kinase (BTK) inhibitor PCI-32765 with bendamustine (B)/rituximab (R) (BR) in patients (pts) with relapsed/refractory (R/R)...
